Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model
Evelien W. Duiker, Elisabeth G.E. De Vries, Devalingam Mahalingam, Gert Jan Meersma, Wytske Boersma Van Ek, Harry Hollema, Marjolijn N.Lub De Hooge, Go M. Van Dam, Robbert H. Cool, Wim J. Quax, Afshin Samali, Ate G.J. Van Der Zee, Steven De Jong*
Dive into the research topics of 'Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model'. Together they form a unique fingerprint.